News
Singapore researchers have discovered that a new cancer drug, originally developed at A*STAR Institute of Molecular and Cell ...
Hosted on MSN10mon
Cancer Coverage Singapore: Should You Get Public or Private ... - MSNImplementation of the Cancer Drug List (CDL) In 2022, the government introduced the Cancer Drug List, which specifies which cancer treatments are eligible for coverage.
Research from Northwestern University shows how a Pfizer-made drug could double as breast cancer prevention and as a way to treat menopause symptoms.
A panel of cancer experts recommended that doctors consider testing before treating patients with a commonly used but sometimes deadly cancer drug. It came too late for many patients.
Scientists use microcellular drones to deliver lung cancer-killing drugs Date: November 11, 2024 Source: National University of Singapore, Yong Loo Lin School of Medicine Summary: Extracellular ...
BostonGene, a leader in AI-powered solutions for drug discovery and development, is transforming how pharmaceutical companies develop, target, and deliver cancer therapies — making precision ...
An "AI scientist," working in collaboration with human scientists, has found that combinations of cheap and safe drugs—used to treat conditions such as high cholesterol and alcohol dependence ...
SINGAPORE: A national cancer consortium here has been admitted into an international expert network that will allow it to participate in global cancer trials.
A new study found a correlation between regular use of a popular over the counter drug and a decreased risk in certain types of cancer.
AstraZeneca said its breast cancer drug candidate showed positive results in a late stage trial, with improved progression-free survival in patients. The British pharma giant said Wednesday that ...
New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more effective than getting weight loss surgery.
A new immunotherapy drug could help some cancer patients avoid surgery. According to the results of a new study in the New England Journal of Medicine, 92% of patients who took this drug were ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results